|
THAP6 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.09200000042442E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.64429999908123E-09 |
| Normal-vs-Stage2 |
8.560800E-04 |
| Normal-vs-Stage3 |
1.643580E-02 |
| Normal-vs-Stage4 |
4.975900E-02 |
| Stage1-vs-Stage2 |
6.209400E-01 |
| Stage1-vs-Stage3 |
6.977600E-03 |
| Stage1-vs-Stage4 |
1.414170E-02 |
| Stage2-vs-Stage3 |
4.526200E-02 |
| Stage2-vs-Stage4 |
4.516200E-02 |
| Stage3-vs-Stage4 |
8.939400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.34249999689851E-08 |
| Normal-vs-AfricanAmerican |
1.621570E-01 |
| Normal-vs-Asian |
5.991900E-04 |
| Caucasian-vs-AfricanAmerican |
6.606300E-02 |
| Caucasian-vs-Asian |
3.711800E-01 |
| AfricanAmerican-vs-Asian |
7.323700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.42759999996767E-06 |
| Normal-vs-Female |
3.2092000001871E-07 |
| Male-vs-Female |
1.925630E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.991000E-01 |
| Normal-vs-Age(41-60Yrs) |
7.03560000259174E-08 |
| Normal-vs-Age(61-80Yrs) |
2.16169999999183E-05 |
| Normal-vs-Age(81-100Yrs) |
1.409840E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.392020E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.115800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.374600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.783700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.369200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.671200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.501200E-03 |
| Normal-vs-Grade 2 |
1.4986000218542E-09 |
| Normal-vs-Grade 3 |
9.93120000000181E-05 |
| Normal-vs-Grade 4 |
9.911200E-01 |
| Grade 1-vs-Grade 2 |
2.694400E-01 |
| Grade 1-vs-Grade 3 |
1.306140E-02 |
| Grade 1-vs-Grade 4 |
1.765300E-04 |
| Grade 2-vs-Grade 3 |
6.944900E-03 |
| Grade 2-vs-Grade 4 |
2.81080000053002E-07 |
| Grade 3-vs-Grade 4 |
1.943970E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.55111512312578E-14 |
| Normal-vs-ccB subtype |
4.182400E-02 |
| ccA subtype-vs-ccB subtype |
2.65800004228822E-09 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.85119999516348E-08 |
| Normal-vs-N1 |
8.602600E-01 |
| N0-vs-N1 |
7.565500E-02 |
|
|
